DURATION-2 Study Group
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
.
Lancet (London, England).
2010
Contact
full name
DURATION-2 Study Group
Quick Info
Collaboration
Co-author network
Map of science